메뉴 건너뛰기




Volumn 11, Issue 5, 2014, Pages 260-271

Li-Fraumeni syndrome: Cancer risk assessment and clinical management

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

EID: 84899925553     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2014.41     Document Type: Review
Times cited : (208)

References (140)
  • 1
    • 78650078754 scopus 로고    scopus 로고
    • Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian Cancer
    • Pruthi, S., Gostout, B. S. & Lindor, N. M. Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian Cancer. Mayo Clin. Proc. 85, 1111-1120 (2010).
    • (2010) Mayo Clin. Proc. , vol.85 , pp. 1111-1120
    • Pruthi, S.1    Gostout, B.S.2    Lindor, N.M.3
  • 2
    • 84876900933 scopus 로고    scopus 로고
    • Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts
    • Vasen, H. F. et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62, 812-823 (2013).
    • (2013) Gut , vol.62 , pp. 812-823
    • Vasen, H.F.1
  • 3
    • 0023715595 scopus 로고
    • A cancer family syndrome in twenty-four kindreds
    • Li, F. P. et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 48, 5358-5362 (1988).
    • (1988) Cancer Res. , vol.48 , pp. 5358-5362
    • Li, F.P.1
  • 4
    • 0028220688 scopus 로고
    • Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-fraumeni families
    • Birch, J. M. et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 54, 1298-1304 (1994).
    • (1994) Cancer Res. , vol.54 , pp. 1298-1304
    • Birch, J.M.1
  • 5
    • 0026324439 scopus 로고
    • Follow up study of 24 families with Li-fraumeni syndrome
    • Garber, J. E. et al. Follow up study of 24 families with Li-Fraumeni syndrome. Cancer Res. 51, 6094-6097 (1991).
    • (1991) Cancer Res. , vol.51 , pp. 6094-6097
    • Garber, J.E.1
  • 6
    • 0032480248 scopus 로고    scopus 로고
    • Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-fraumeni syndrome
    • Birch, J. M. et al. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 17, 1061-1068 (1998).
    • (1998) Oncogene , vol.17 , pp. 1061-1068
    • Birch, J.M.1
  • 7
    • 0025633582 scopus 로고
    • Germ line p53 mutations in a familial syndrome of breast-cancer, sarcomas, and other neoplasms
    • Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast-cancer, sarcomas, and other neoplasms. Science 250, 1233-1238 (1990).
    • (1990) Science , vol.250 , pp. 1233-1238
    • Malkin, D.1
  • 8
    • 77953718900 scopus 로고    scopus 로고
    • TP53 germline mutation testing in 180 families suspected of Li-fraumeni syndrome: Mutation detection rate and relative frequency of cancers in different familial phenotypes
    • Ruijs, M. W. et al. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J. Med. Genet. 47, 421-428 (2010).
    • (2010) J. Med. Genet. , vol.47 , pp. 421-428
    • Ruijs, M.W.1
  • 10
    • 84867671998 scopus 로고    scopus 로고
    • Li-fraumeni syndrome: Report of a clinical research workshop and creation of a research consortium
    • Mai, P. L. et al. Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet. 205, 479-487 (2012).
    • (2012) Cancer Genet. , vol.205 , pp. 479-487
    • Mai, P.L.1
  • 11
    • 0030806921 scopus 로고    scopus 로고
    • Germ-line mutations of TP53 in Li-fraumeni families: An extended study of 39 families
    • Varley, J. M. et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res. 57, 3245-3252 (1997).
    • (1997) Cancer Res. , vol.57 , pp. 3245-3252
    • Varley, J.M.1
  • 12
    • 0345269984 scopus 로고    scopus 로고
    • Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk
    • Hwang, S. J., Lozano, G., Amos, C. I. & Strong, L. C. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am. J. Hum. Genet. 72, 975-983 (2003).
    • (2003) Am. J. Hum. Genet. , vol.72 , pp. 975-983
    • Hwang, S.J.1    Lozano, G.2    Amos, C.I.3    Strong, L.C.4
  • 13
    • 0026665911 scopus 로고
    • Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients
    • Lustbader, E. D., Williams, W. R., Bondy, M. L., Strom, S. & Strong, L. C. Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am. J. Hum. Genet. 51, 344-356 (1992).
    • (1992) Am. J. Hum. Genet. , vol.51 , pp. 344-356
    • Lustbader, E.D.1    Williams, W.R.2    Bondy, M.L.3    Strom, S.4    Strong, L.C.5
  • 15
    • 0034071085 scopus 로고    scopus 로고
    • P53 germline mutations in childhood cancers and cancer risk for carrier individuals
    • Chompret, A. et al. p53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br. J. Cancer 82, 1932-1937 (2000).
    • (2000) Br. J. Cancer , vol.82 , pp. 1932-1937
    • Chompret, A.1
  • 16
    • 84899988606 scopus 로고    scopus 로고
    • Cancer Institute NSW. [online]
    • Cancer Institute NSW. eviQ Cancer Treatments Online [online], https://www.eviq.org.au/Protocol/tabid/66/categoryid/66/id/749/ Risk+Management+for+Li-Fraumeni+Syndrome.aspx (2013).
    • (2013) EviQ Cancer Treatments Online
  • 17
    • 0142157701 scopus 로고    scopus 로고
    • Li-fraumeni and related syndromes: Correlation between tumor type, family structure, and TP53 genotype
    • Olivier, M. et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 63, 6643-6650 (2003).
    • (2003) Cancer Res. , vol.63 , pp. 6643-6650
    • Olivier, M.1
  • 18
    • 84880660114 scopus 로고    scopus 로고
    • High frequency of Germline TP53 mutations in a prospective adult-onset sarcoma cohort
    • Mitchell, G. et al. High Frequency of Germline TP53 mutations in a prospective adult-onset sarcoma cohort. PLoS ONE 8, e69026 (2013).
    • (2013) PLoS ONE , vol.8
    • Mitchell, G.1
  • 19
    • 0029558570 scopus 로고
    • Germline mutations in the TP53 gene
    • Eeles, R. A. Germline mutations in the TP53 gene. Cancer Surv. 25, 101-124 (1995).
    • (1995) Cancer Surv. , vol.25 , pp. 101-124
    • Eeles, R.A.1
  • 20
    • 70349320378 scopus 로고    scopus 로고
    • 2009 version of the chompret criteria for Li-fraumeni syndrome
    • Tinat, J. et al. 2009 version of the Chompret criteria for Li-Fraumeni syndrome. J. Clin. Oncol. 27, E108-E109 (2009).
    • (2009) J. Clin. Oncol. , vol.27
    • Tinat, J.1
  • 21
    • 84873459266 scopus 로고    scopus 로고
    • Tumor protein p53 (TP53) testing and Li-fraumeni syndrome: Current status of clinical applications and future directions
    • Sorrell, A. D., Espenschied, C. R., Culver, J. O. & Weitzel, J. N. Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions. Mol. Diagn. Ther. 17, 31-47 (2013).
    • (2013) Mol. Diagn. Ther. , vol.17 , pp. 31-47
    • Sorrell, A.D.1    Espenschied, C.R.2    Culver, J.O.3    Weitzel, J.N.4
  • 22
    • 33748060942 scopus 로고    scopus 로고
    • Joint effects of germ-line p53 mutation and sex on cancer risk in Li-fraumeni syndrome
    • Wu, C. C., Shete, S., Amos, C. I. & Strong, L. C. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res. 66, 8287-8292 (2006).
    • (2006) Cancer Res. , vol.66 , pp. 8287-8292
    • Wu, C.C.1    Shete, S.2    Amos, C.I.3    Strong, L.C.4
  • 23
    • 80053022230 scopus 로고    scopus 로고
    • Li-fraumeni syndrome
    • Malkin, D. Li-Fraumeni syndrome. Genes Cancer 2, 475-484 (2011).
    • (2011) Genes Cancer , vol.2 , pp. 475-484
    • Malkin, D.1
  • 24
    • 84857356609 scopus 로고    scopus 로고
    • Sarcomas in TP53 germline mutation carriers a review of the IARC TP53 database
    • Ognjanovic, S., Olivier, M., Bergemann, T. L. & Hainaut, P. Sarcomas in TP53 germline mutation carriers a review of the IARC TP53 database. Cancer 118, 1387-1396 (2012).
    • (2012) Cancer , vol.118 , pp. 1387-1396
    • Ognjanovic, S.1    Olivier, M.2    Bergemann, T.L.3    Hainaut, P.4
  • 25
    • 34248379012 scopus 로고    scopus 로고
    • Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database
    • Petitjean, A. et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 28, 622-629 (2007).
    • (2007) Hum. Mutat. , vol.28 , pp. 622-629
    • Petitjean, A.1
  • 26
    • 84863717944 scopus 로고    scopus 로고
    • Breast cancer phenotype in women with TP53 germline mutations: A Li-fraumeni syndrome consortium effort
    • Masciari, S. et al. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res. Treat. 133, 1125-1130 (2012).
    • (2012) Breast Cancer Res. Treat. , vol.133 , pp. 1125-1130
    • Masciari, S.1
  • 27
    • 77951629484 scopus 로고    scopus 로고
    • TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors
    • Tabori, U. et al. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J. Clin. Oncol. 28, 1995-2001 (2010).
    • (2010) J. Clin. Oncol. , vol.28 , pp. 1995-2001
    • Tabori, U.1
  • 28
    • 84899909713 scopus 로고    scopus 로고
    • Striking survival benefit with early detection of brain tumors for children with Li-fraumeni syndrome
    • Villani, A. et al. Striking survival benefit with early detection of brain tumors for children with Li-Fraumeni syndrome. Neuro-Oncology 12, ii35-ii36 (2010).
    • (2010) Neuro-Oncology , vol.12
    • Villani, A.1
  • 29
    • 30044447282 scopus 로고    scopus 로고
    • Prevalence of early onset colorectal cancer in 397 patients with classic Li-fraumeni syndrome
    • Wong, P. et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 130, 73-79 (2006).
    • (2006) Gastroenterology , vol.130 , pp. 73-79
    • Wong, P.1
  • 30
    • 79960845375 scopus 로고    scopus 로고
    • Gastric cancer in individuals with Li-fraumeni syndrome
    • Masciari, S. et al. Gastric cancer in individuals with Li-Fraumeni syndrome. Genet. Med. 13, 651-657 (2011).
    • (2011) Genet. Med. , vol.13 , pp. 651-657
    • Masciari, S.1
  • 32
    • 0035797528 scopus 로고    scopus 로고
    • Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    • Birch, J. M. et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20, 4621-4628 (2001).
    • (2001) Oncogene , vol.20 , pp. 4621-4628
    • Birch, J.M.1
  • 33
    • 62449249871 scopus 로고    scopus 로고
    • Beyond Li-fraumeni syndrome: Clinical characteristics of families with p53 germline mutations
    • Gonzalez, K. D. et al. Beyond Li-Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J. Clin. Oncol. 26, 1250-1256 (2008).
    • (2008) J. Clin. Oncol. , vol.26 , pp. 1250-1256
    • Gonzalez, K.D.1
  • 35
    • 84899936151 scopus 로고    scopus 로고
    • Multiple malignancies in Li-fraumeni syndrome: Younger age at first onset the strongest predictor
    • Ross, J. A. Multiple malignancies in Li-Fraumeni syndrome: younger age at first onset the strongest predictor. Med. Pediatr. Oncol. 33, 108-109 (1999).
    • (1999) Med. Pediatr. Oncol. , vol.33 , pp. 108-109
    • Ross, J.A.1
  • 36
    • 79958169763 scopus 로고    scopus 로고
    • Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53
    • Ferrarini, A. et al. Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53. Fam. Cancer 10, 187-192 (2011).
    • (2011) Fam. Cancer , vol.10 , pp. 187-192
    • Ferrarini, A.1
  • 37
    • 84865329221 scopus 로고    scopus 로고
    • Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-fraumeni syndrome
    • Henry, E. et al. Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome. J. Natl Compr. Canc. Netw. 10, 939-942 (2012).
    • (2012) J. Natl Compr. Canc. Netw. , vol.10 , pp. 939-942
    • Henry, E.1
  • 38
    • 78049484759 scopus 로고    scopus 로고
    • Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-fraumeni syndrome
    • Heymann, S. et al. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat. Oncol. 5, 104 (2010).
    • (2010) Radiat. Oncol. , vol.5 , pp. 104
    • Heymann, S.1
  • 39
    • 0035921190 scopus 로고    scopus 로고
    • Two metachronous tumors in the radiotherapy fields of a patient with Li-fraumeni syndrome
    • Limacher, J. M., Frebourg, T., Natarajan-Ame, S. & Bergerat, J. P. Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome. Int. J. Cancer 96, 238-242 (2001).
    • (2001) Int. J. Cancer , vol.96 , pp. 238-242
    • Limacher, J.M.1    Frebourg, T.2    Natarajan-Ame, S.3    Bergerat, J.P.4
  • 40
    • 34547507687 scopus 로고    scopus 로고
    • Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation
    • Salmon, A. et al. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Clin. Oncol. 19, 490-493 (2007).
    • (2007) Clin. Oncol. , vol.19 , pp. 490-493
    • Salmon, A.1
  • 41
    • 0028168643 scopus 로고
    • P53 deficient mice are extremely susceptible to radiotion-induced tumorigenesis
    • Kemp, C. J., Wheldon, T. & Balmain, A. p53 deficient mice are extremely susceptible to radiotion-induced tumorigenesis. Nat. Genet. 8, 66-69 (1994).
    • (1994) Nat. Genet. , vol.8 , pp. 66-69
    • Kemp, C.J.1    Wheldon, T.2    Balmain, A.3
  • 42
    • 0042566080 scopus 로고    scopus 로고
    • Lung cancer risk in germline p53 mutation carriers: Association between an inherited cancer predisposition, cigarette smoking, and cancer risk
    • Hwang, S. J. et al. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum. Genet. 113, 238-243 (2003).
    • (2003) Hum. Genet. , vol.113 , pp. 238-243
    • Hwang, S.J.1
  • 43
    • 70349443284 scopus 로고    scopus 로고
    • When mutants gain new powers: News from the mutant p53 field
    • Brosh, R. & Rotter, V. When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9, 701-713 (2009).
    • (2009) Nat. Rev. Cancer , vol.9 , pp. 701-713
    • Brosh, R.1    Rotter, V.2
  • 46
    • 0037816165 scopus 로고    scopus 로고
    • Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
    • Kato, S. et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl Acad. Sci. USA 100, 8424-8429 (2003).
    • (2003) Proc. Natl Acad. Sci. USA , vol.100 , pp. 8424-8429
    • Kato, S.1
  • 47
    • 84872485671 scopus 로고    scopus 로고
    • Wellcome Trust Sanger Institute. [online]
    • Wellcome Trust Sanger Institute. COSMIC: Catologue of Somatic Mutation in Cancer [online], http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/ (2014).
    • (2014) COSMIC: Catologue of Somatic Mutation in Cancer
  • 48
    • 84877028141 scopus 로고    scopus 로고
    • Comprehensive molecular portraits of human breast tumours
    • Koboldt, D. C. et al. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
    • (2012) Nature , vol.490 , pp. 61-70
    • Koboldt, D.C.1
  • 49
    • 84863922124 scopus 로고    scopus 로고
    • Comprehensive molecular characterization of human colon and rectal cancer
    • Cancer Genome Atlas Network
    • Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
    • (2012) Nature , vol.487 , pp. 330-337
  • 50
    • 0024382760 scopus 로고
    • The p53 proto-oncogene can act as a suppressor of transformation
    • Finlay, C. A., Hinds, P. W. & Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57, 1083-1093 (1989).
    • (1989) Cell , vol.57 , pp. 1083-1093
    • Finlay, C.A.1    Hinds, P.W.2    Levine, A.J.3
  • 51
    • 8844278362 scopus 로고    scopus 로고
    • A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
    • Bond, G. L. et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119, 591-602 (2004).
    • (2004) Cell , vol.119 , pp. 591-602
    • Bond, G.L.1
  • 52
    • 33845530151 scopus 로고    scopus 로고
    • The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-fraumeni syndrome and related phenotypes
    • Ruijs, M. et al. The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes. Eur. J. Hum. Genet. 15, 110-114 (2006).
    • (2006) Eur. J. Hum. Genet. , vol.15 , pp. 110-114
    • Ruijs, M.1
  • 53
    • 33745235771 scopus 로고    scopus 로고
    • Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-fraumeni syndrome
    • Bougeard, G. et al. Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J. Med. Genet. 43, 531-533 (2006).
    • (2006) J. Med. Genet. , vol.43 , pp. 531-533
    • Bougeard, G.1
  • 54
    • 77956499678 scopus 로고    scopus 로고
    • Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations
    • Fang, S. et al. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS ONE 5, e10813 (2010).
    • (2010) PLoS ONE , vol.5
    • Fang, S.1
  • 56
    • 72449128179 scopus 로고    scopus 로고
    • TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-fraumeni syndrome: Impact on age at first diagnosis
    • Marcel, V. et al. TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. J. Med. Genet. 46, 766-772 (2009).
    • (2009) J. Med. Genet. , vol.46 , pp. 766-772
    • Marcel, V.1
  • 57
    • 79959733533 scopus 로고    scopus 로고
    • Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-fraumeni syndrome
    • Wu, C.-C. et al. Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Hum. Genet. 129, 663-673 (2011).
    • (2011) Hum. Genet. , vol.129 , pp. 663-673
    • Wu, C.-C.1
  • 58
    • 0036336521 scopus 로고    scopus 로고
    • Is there anticipation in the age at onset of cancer in families with Li-fraumeni syndrome?
    • Trkova, M., Hladikova, M., Kasal, P., Goetz, P. & Sedlacek, Z. Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome? J. Hum. Genet. 47, 381-386 (2002).
    • (2002) J. Hum. Genet. , vol.47 , pp. 381-386
    • Trkova, M.1    Hladikova, M.2    Kasal, P.3    Goetz, P.4    Sedlacek, Z.5
  • 59
    • 34547123315 scopus 로고    scopus 로고
    • Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age
    • Trkova, M., Prochazkova, K., Krutilkova, V., Sumerauer, D. & Sedlacek, Z. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age. Cancer 110, 694-702 (2007).
    • (2007) Cancer , vol.110 , pp. 694-702
    • Trkova, M.1    Prochazkova, K.2    Krutilkova, V.3    Sumerauer, D.4    Sedlacek, Z.5
  • 60
    • 33847691863 scopus 로고    scopus 로고
    • Younger age of cancer initiation is associated with shorter telomere length in Li-fraumeni syndrome
    • Tabori, U., Nanda, S., Druker, H., Lees, J. & Malkin, D. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res. 67, 1415-1418 (2007).
    • (2007) Cancer Res. , vol.67 , pp. 1415-1418
    • Tabori, U.1    Nanda, S.2    Druker, H.3    Lees, J.4    Malkin, D.5
  • 61
    • 49649110984 scopus 로고    scopus 로고
    • Excessive genomic DNA copy number variation in the Li-fraumeni cancer predisposition syndrome
    • Shlien, A. et al. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc. Natl Acad. Sci. USA 105, 11264-11269 (2008).
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , pp. 11264-11269
    • Shlien, A.1
  • 62
    • 78650959663 scopus 로고    scopus 로고
    • Massive genomic rearrangement acquired in a single catastrophic event during cancer development
    • Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
    • (2011) Cell , vol.144 , pp. 27-40
    • Stephens, P.J.1
  • 63
    • 84862907577 scopus 로고    scopus 로고
    • Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations
    • Rausch, T. et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59-71 (2012).
    • (2012) Cell , vol.148 , pp. 59-71
    • Rausch, T.1
  • 65
    • 84899962299 scopus 로고    scopus 로고
    • National Breast and Ovarian Cancer Centre. [online]
    • National Breast and Ovarian Cancer Centre. Early detection of breast cancer NBOCC position statement [online], http://canceraustralia.gov.au/ publications-and-resources/position-statements/early-detection-breast-cancer (2009).
    • (2009) Early Detection of Breast Cancer NBOCC Position Statement
  • 66
    • 84869499447 scopus 로고    scopus 로고
    • Local recurrence of localized soft tissue sarcoma: A new look at old predictors
    • Biau, D. J. et al. Local recurrence of localized soft tissue sarcoma: a new look at old predictors. Cancer 118, 5867-5877 (2012).
    • (2012) Cancer , vol.118 , pp. 5867-5877
    • Biau, D.J.1
  • 67
    • 77957722351 scopus 로고    scopus 로고
    • Do surgical margin and local recurrence influence survival in soft tissue sarcomas?
    • Novais, E. N. et al. Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin. Orthop. Relat. Res. 468, 3003-3011 (2010).
    • (2010) Clin. Orthop. Relat. Res. , vol.468 , pp. 3003-3011
    • Novais, E.N.1
  • 68
    • 0036490588 scopus 로고    scopus 로고
    • Prognostic factors in soft tissue sarcomas: A study of 395 patients
    • Stefanovski, P. D. et al. Prognostic factors in soft tissue sarcomas: a study of 395 patients. Eur. J. Surg. Oncol. 28, 153-164 (2002).
    • (2002) Eur. J. Surg. Oncol. , vol.28 , pp. 153-164
    • Stefanovski, P.D.1
  • 69
    • 75149189218 scopus 로고    scopus 로고
    • Neurooncology of familial cancer syndromes
    • Hottinger, A. F. & Khakoo, Y. Neurooncology of familial cancer syndromes. J. Child Neurol. 24, 1526-1535 (2009).
    • (2009) J. Child Neurol. , vol.24 , pp. 1526-1535
    • Hottinger, A.F.1    Khakoo, Y.2
  • 70
    • 84865447852 scopus 로고    scopus 로고
    • The assessment of prognostic factors in surgical treatment of low-grade gliomas: A prospective study
    • Majchrzak, K. et al. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study. Clin. Neurol. Neurosurg. 114, 1135-1144 (2012).
    • (2012) Clin. Neurol. Neurosurg. , vol.114 , pp. 1135-1144
    • Majchrzak, K.1
  • 72
    • 84899971026 scopus 로고    scopus 로고
    • Prognostic factors for survival and recurrence in adult medulloblastoma
    • Krauze, A. V. et al. Prognostic factors for survival and recurrence in adult medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys. 78, S269-S269 (2010).
    • (2010) Int. J. Radiat. Oncol. Biol. Phys. , vol.78
    • Krauze, A.V.1
  • 73
    • 28444444416 scopus 로고    scopus 로고
    • Second surgery and the prognosis of choroid plexus carcinoma-results of a meta-analysis of individual cases
    • Wrede, B., Liu, P., Ater, J. & Wolff, J. E. Second surgery and the prognosis of choroid plexus carcinoma-results of a meta-analysis of individual cases. Anticancer Res. 25, 4429-4433 (2005).
    • (2005) Anticancer Res. , vol.25 , pp. 4429-4433
    • Wrede, B.1    Liu, P.2    Ater, J.3    Wolff, J.E.4
  • 75
    • 1542713361 scopus 로고    scopus 로고
    • Clinical and outcome characteristics of children with adrenocortical tumors: A report from the international pediatric adrenocortical tumor registry
    • Michalkiewicz, E. et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry. J. Clin. Oncol. 22, 838-845 (2004).
    • (2004) J. Clin. Oncol. , vol.22 , pp. 838-845
    • Michalkiewicz, E.1
  • 77
    • 0033396346 scopus 로고    scopus 로고
    • Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma
    • Schulick, R. D. & Brennan, M. F. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann. Surg. Oncol. 6, 719-726 (1999).
    • (1999) Ann. Surg. Oncol. , vol.6 , pp. 719-726
    • Schulick, R.D.1    Brennan, M.F.2
  • 78
    • 84883867131 scopus 로고    scopus 로고
    • Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors
    • Custodio, G. et al. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J. Clin. Oncol. 31, 2619-2626 (2013).
    • (2013) J. Clin. Oncol. , vol.31 , pp. 2619-2626
    • Custodio, G.1
  • 79
    • 84862986429 scopus 로고    scopus 로고
    • Long-term results of screening with magnetic resonance imaging in women with BRCA mutations
    • Passaperuma, K. et al. Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. Br. J. Cancer 107, 24-30 (2012).
    • (2012) Br. J. Cancer , vol.107 , pp. 24-30
    • Passaperuma, K.1
  • 80
    • 79951860891 scopus 로고    scopus 로고
    • BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: Long-term follow-up of the Dutch MRISC screening study
    • Rijnsburger, A. J. et al. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC screening study. J. Clin. Oncol. 28, 5265-5273 (2010).
    • (2010) J. Clin. Oncol. , vol.28 , pp. 5265-5273
    • Rijnsburger, A.J.1
  • 81
    • 79959587205 scopus 로고    scopus 로고
    • Clinical management of hereditary breast cancer syndromes
    • Clark, A. S. & Domchek, S. M. Clinical management of hereditary breast cancer syndromes. J. Mammary Gland Biol. Neoplasia 16, 17-25 (2011).
    • (2011) J. Mammary Gland Biol. Neoplasia , vol.16 , pp. 17-25
    • Clark, A.S.1    Domchek, S.M.2
  • 82
    • 19744380352 scopus 로고    scopus 로고
    • Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS)
    • Leach, M. O. et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365, 1769-1778 (2005).
    • (2005) Lancet , vol.365 , pp. 1769-1778
    • Leach, M.O.1
  • 83
    • 33947546554 scopus 로고    scopus 로고
    • Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
    • Kriege, M. et al. Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res. Treat. 102, 357-363 (2007).
    • (2007) Breast Cancer Res. Treat. , vol.102 , pp. 357-363
    • Kriege, M.1
  • 84
    • 77957331968 scopus 로고    scopus 로고
    • Radiation doses and cancer risks from breast imaging studies
    • Hendrick, R. E. Radiation doses and cancer risks from breast imaging studies. Radiology 257, 246-253 (2010).
    • (2010) Radiology , vol.257 , pp. 246-253
    • Hendrick, R.E.1
  • 85
    • 0032578325 scopus 로고    scopus 로고
    • A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult
    • Towler, B. et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 317, 559-565 (1998).
    • (1998) BMJ , vol.317 , pp. 559-565
    • Towler, B.1
  • 86
    • 0036906436 scopus 로고    scopus 로고
    • Surveillance for hereditary nonpolyposis colorectal cancer: A long-term study on 114 families
    • de Vos tot Nederveen Cappel, W. H. et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis. Colon Rectum 45, 1588-1594 (2002).
    • (2002) Dis. Colon Rectum , vol.45 , pp. 1588-1594
    • De Vos-Tot Nederveen-Cappel, W.H.1
  • 87
    • 84861639726 scopus 로고    scopus 로고
    • Efficacy of a nationwide screening colonoscopy program for colorectal cancer
    • Pox, C. P. et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 142, 1460-1472 (2012).
    • (2012) Gastroenterology , vol.142 , pp. 1460-1472
    • Pox, C.P.1
  • 88
    • 0033935532 scopus 로고    scopus 로고
    • Impact of screening survey of gastric cancer on clinicopathological features and survival: Retrospective study at a single institution
    • Kubota, H. et al. Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution. Surgery 128, 41-47 (2000).
    • (2000) Surgery , vol.128 , pp. 41-47
    • Kubota, H.1
  • 89
    • 84855391821 scopus 로고    scopus 로고
    • Gastric tumours in hereditary cancer syndromes: Clinical features, molecular biology and strategies for prevention
    • Sereno, M. et al. Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention. Clin. Transl. Oncol. 13, 599-610 (2011).
    • (2011) Clin. Transl. Oncol. , vol.13 , pp. 599-610
    • Sereno, M.1
  • 90
    • 40949118501 scopus 로고    scopus 로고
    • F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-fraumeni syndrome
    • Masciari, S. et al. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA 299, 1315-1319 (2008).
    • (2008) JAMA , vol.299 , pp. 1315-1319
    • Masciari, S.1
  • 91
    • 63249095226 scopus 로고    scopus 로고
    • Radiation-sensitive genetically susceptible pediatric sub-populations
    • Kleinerman, R. A. Radiation-sensitive genetically susceptible pediatric sub-populations. Pediatr. Radiol. 39, S27-S31 (2009).
    • (2009) Pediatr. Radiol. , vol.39
    • Kleinerman, R.A.1
  • 92
    • 0037222381 scopus 로고    scopus 로고
    • Germline TP53 mutations and Li-fraumeni syndrome
    • Varley, J. M. Germline TP53 mutations and Li-Fraumeni syndrome. Hum. Mutat. 21, 313-320 (2003).
    • (2003) Hum. Mutat. , vol.21 , pp. 313-320
    • Varley, J.M.1
  • 93
    • 79957474904 scopus 로고    scopus 로고
    • Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-fraumeni syndrome: A prospective observational study
    • Villani, A. et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol. 12, 559-567 (2011).
    • (2011) Lancet Oncol. , vol.12 , pp. 559-567
    • Villani, A.1
  • 94
    • 84859393143 scopus 로고    scopus 로고
    • Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
    • Canto, M. I. et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142, 796-804 (2012).
    • (2012) Gastroenterology , vol.142 , pp. 796-804
    • Canto, M.I.1
  • 95
    • 79958278810 scopus 로고    scopus 로고
    • Magnetic resonance imaging for lung cancer detection: Experience in a population of more than 10,000 healthy individuals
    • Wu, N.-Y. et al. Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals. BMC Cancer 11, 242 (2011).
    • (2011) BMC Cancer , vol.11 , pp. 242
    • Wu, N.-Y.1
  • 96
    • 37249013214 scopus 로고    scopus 로고
    • US National Library of Medicine. [online]
    • US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/show/NCT01737255 (2012).
    • (2012) ClinicalTrials.gov
  • 97
    • 37249013214 scopus 로고    scopus 로고
    • US National Library of Medicine. [online]
    • US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/show/NCT01464086 (2014).
    • (2014) ClinicalTrials.gov
  • 98
    • 84899986779 scopus 로고    scopus 로고
    • ANZCTR: Australia New Zealand Clinical Trials Registry. [online]
    • ANZCTR: Australia New Zealand Clinical Trials Registry. Trial from ANZCTR [online], http://www.ANZCTR.org.au/ACTRN12613000987763.aspx (2013).
    • (2013) Trial from ANZCTR
  • 99
    • 0014345394 scopus 로고
    • Principles and practice of screening for disease
    • Wilson, J. M. & Jungner, G. Principles and practice of screening for disease. Bol. Oficina Sanit. Panam. 65, 281-393 (1968).
    • (1968) Bol. Oficina Sanit. Panam. , vol.65 , pp. 281-393
    • Wilson, J.M.1    Jungner, G.2
  • 100
    • 1842687891 scopus 로고    scopus 로고
    • New concepts in screening
    • Gray, J. A. New concepts in screening. Br. J. Gen. Pract. 54, 292-298 (2004).
    • (2004) Br. J. Gen. Pract. , vol.54 , pp. 292-298
    • Gray, J.A.1
  • 103
    • 78650217249 scopus 로고    scopus 로고
    • Regular surveillance for Li-fraumeni Syndrome: Advice, adherence and perceived benefits
    • Lammens, C. R. et al. Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits. Fam. Cancer 9, 647-654 (2010).
    • (2010) Fam. Cancer , vol.9 , pp. 647-654
    • Lammens, C.R.1
  • 104
    • 79951654673 scopus 로고    scopus 로고
    • Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: The MARIBS Study
    • Hutton, J. et al. Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study. Br. J. Cancer 104, 578-586 (2011).
    • (2011) Br. J. Cancer , vol.104 , pp. 578-586
    • Hutton, J.1
  • 105
    • 78650223070 scopus 로고    scopus 로고
    • Pancreatic cancer risk counselling and screening: Impact on perceived risk and psychological functioning
    • Maheu, C. et al. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam. Cancer 9, 617-624 (2010).
    • (2010) Fam. Cancer , vol.9 , pp. 617-624
    • Maheu, C.1
  • 106
    • 84864944363 scopus 로고    scopus 로고
    • Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden?-A systematic review
    • Gopie, J. P., Vasen, H. F. A. & Tibben, A. Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?-a systematic review. Crit. Rev. Oncol. Hematol. 83, 329-340 (2012).
    • (2012) Crit. Rev. Oncol. Hematol. , vol.83 , pp. 329-340
    • Gopie, J.P.1    Vasen, H.F.A.2    Tibben, A.3
  • 107
    • 33847793068 scopus 로고    scopus 로고
    • Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial
    • Cuzick, J. et al. Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial. J. Natl Cancer Inst. 99, 272-282 (2007).
    • (2007) J. Natl Cancer Inst. , vol.99 , pp. 272-282
    • Cuzick, J.1
  • 108
    • 27944492407 scopus 로고    scopus 로고
    • Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    • Fisher, B. et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J. Natl Cancer Inst. 97, 1652-1662 (2005).
    • (2005) J. Natl Cancer Inst. , vol.97 , pp. 1652-1662
    • Fisher, B.1
  • 109
    • 0037183243 scopus 로고    scopus 로고
    • Update on effects of screening mammography
    • Tabar, L., Smith, R. A. & Duffy, S. W. Update on effects of screening mammography. Lancet 360, 337-337 (2002).
    • (2002) Lancet , vol.360 , pp. 337-337
    • Tabar, L.1    Smith, R.A.2    Duffy, S.W.3
  • 110
    • 75749101319 scopus 로고    scopus 로고
    • Screening for breast cancer with mammography
    • Art. No.: CD001877
    • Gøtzsche, P. C. & Nielsen, M. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews, Issue 1, Art. No.: CD001877 http://dx.doi.org/10.1002/14651858.CD001877.pub4.
    • Cochrane Database of Systematic Reviews , Issue.1
    • Gøtzsche, P.C.1    Nielsen, M.2
  • 111
    • 77956193440 scopus 로고    scopus 로고
    • Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
    • Domchek, S. M. et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304, 967-975 (2010).
    • (2010) JAMA , vol.304 , pp. 967-975
    • Domchek, S.M.1
  • 112
    • 15444361731 scopus 로고    scopus 로고
    • Predictive factors for local recurrence in osteosarcoma-540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy
    • Bacci, G. et al. Predictive factors for local recurrence in osteosarcoma-540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop. Scand. 69, 230-236 (1998).
    • (1998) Acta Orthop. Scand. , vol.69 , pp. 230-236
    • Bacci, G.1
  • 113
    • 79955505062 scopus 로고    scopus 로고
    • The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
    • Andreou, D. et al. The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann. Oncol. 22, 1228-1235 (2011).
    • (2011) Ann. Oncol. , vol.22 , pp. 1228-1235
    • Andreou, D.1
  • 114
    • 79955507146 scopus 로고    scopus 로고
    • Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil
    • Seidinger, A. L. et al. Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil. Cancer 117, 2228-2235 (2011).
    • (2011) Cancer , vol.117 , pp. 2228-2235
    • Seidinger, A.L.1
  • 115
    • 0030861027 scopus 로고    scopus 로고
    • Bladder cancer: Natural history, tumor markers, and early detection strategies
    • Foresman, W. H. & Messing, E. M. Bladder cancer: natural history, tumor markers, and early detection strategies. Semin. Surg. Oncol. 13, 299-306 (1997).
    • (1997) Semin. Surg. Oncol. , vol.13 , pp. 299-306
    • Foresman, W.H.1    Messing, E.M.2
  • 116
    • 0026704550 scopus 로고
    • The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients-A significant trend of earlier cancer-detection from 1982 through 1988 at a university hospital
    • Cappell, M. S. & Goldberg, E. S. The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients-a significant trend of earlier cancer-detection from 1982 through 1988 at a university hospital. J. Clin. Gastroenterol. 14, 227-235 (1992).
    • (1992) J. Clin. Gastroenterol. , vol.14 , pp. 227-235
    • Cappell, M.S.1    Goldberg, E.S.2
  • 118
    • 84899984910 scopus 로고    scopus 로고
    • Bowel cancer chemoprevention-ready for the clinic?
    • Burn, J. Bowel cancer chemoprevention-ready for the clinic? Hered. Cancer Clin. Pract. 10 (Suppl. 2), A12 (2011).
    • (2011) Hered. Cancer Clin. Pract. , vol.10 , Issue.SUPPL. 2
    • Burn, J.1
  • 119
    • 0035195059 scopus 로고    scopus 로고
    • Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival
    • Mori, Y. et al. Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival. Gastric Cancer 4, 132-136 (2001).
    • (2001) Gastric Cancer , vol.4 , pp. 132-136
    • Mori, Y.1
  • 120
    • 35348979737 scopus 로고    scopus 로고
    • Sporadic kidney cancer in patients younger than 45 [French]
    • Battisti, S., Braud, G., Rigaud, J. & Bouchot, O. Sporadic kidney cancer in patients younger than 45 [French]. Prog. Urol. 17, 934-938 (2007).
    • (2007) Prog. Urol. , vol.17 , pp. 934-938
    • Battisti, S.1    Braud, G.2    Rigaud, J.3    Bouchot, O.4
  • 121
    • 36448951228 scopus 로고    scopus 로고
    • Wilms tumour: Prognostic factors, staging, therapy and late effects
    • Kaste, S. et al. Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr. Radiol. 38, 2-17 (2008).
    • (2008) Pediatr. Radiol. , vol.38 , pp. 2-17
    • Kaste, S.1
  • 122
    • 80051879921 scopus 로고    scopus 로고
    • Hepatoblastoma: 15-year experience and role of surgical treatment
    • Moon, S. B., Shin, H. B., Seo, J. M. & Lee, S. K. Hepatoblastoma: 15-year experience and role of surgical treatment. J. Korean Surg. Soc. 81, 134-140 (2011).
    • (2011) J. Korean Surg. Soc. , vol.81 , pp. 134-140
    • Moon, S.B.1    Shin, H.B.2    Seo, J.M.3    Lee, S.K.4
  • 123
    • 0033934756 scopus 로고    scopus 로고
    • Pretreatment prognostic factors for children with hepatoblastoma results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1
    • Brown, J. et al. Pretreatment prognostic factors for children with hepatoblastoma results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1. Eur. J. Cancer 36, 1418-1425 (2000).
    • (2000) Eur. J. Cancer , vol.36 , pp. 1418-1425
    • Brown, J.1
  • 124
    • 84870525789 scopus 로고    scopus 로고
    • Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: A cohort study
    • Veronesi, G. et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann. Intern. Med. 157, 776-784 (2012).
    • (2012) Ann. Intern. Med. , vol.157 , pp. 776-784
    • Veronesi, G.1
  • 125
    • 0034548744 scopus 로고    scopus 로고
    • Stage i nonsmall cell lung carcinoma: Analysis of survival and implications for screening
    • Dominioni, L. et al. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening. Cancer 89, 2334-2344 (2000).
    • (2000) Cancer , vol.89 , pp. 2334-2344
    • Dominioni, L.1
  • 126
    • 82155195577 scopus 로고    scopus 로고
    • Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: Long-term outcome of 36 malignant phyllodes tumors
    • Abe, M. et al. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer 18, 268-272 (2011).
    • (2011) Breast Cancer , vol.18 , pp. 268-272
    • Abe, M.1
  • 127
    • 15744372047 scopus 로고    scopus 로고
    • The role of pathologic parameters
    • Tan, P. H. et al. The role of pathologic parameters. Am J. Clin. Pathol. 123, 529-540 (2005).
    • (2005) Am J. Clin. Pathol. , vol.123 , pp. 529-540
    • Tan, P.H.1
  • 128
    • 0025277124 scopus 로고
    • Screening and surveillance of patients at high-risk for malignant-melanoma result in detection of earlier disease
    • Masri, G. D. et al. Screening and surveillance of patients at high-risk for malignant-melanoma result in detection of earlier disease. J. Am. Acad. Dermatol. 22, 1042-1048 (1990).
    • (1990) J. Am. Acad. Dermatol. , vol.22 , pp. 1042-1048
    • Masri, G.D.1
  • 129
    • 79960384627 scopus 로고    scopus 로고
    • Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families
    • van der Rhee, J. I. et al. Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families. J. Am. Acad. Dermatol. 65, 289-296 (2011).
    • (2011) J. Am. Acad. Dermatol. , vol.65 , pp. 289-296
    • Van Der-Rhee, J.I.1
  • 130
    • 77952239366 scopus 로고    scopus 로고
    • Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
    • Leiter, U. et al. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Res. 20, 240-246 (2010).
    • (2010) Melanoma Res. , vol.20 , pp. 240-246
    • Leiter, U.1
  • 131
    • 80052975815 scopus 로고    scopus 로고
    • Serial screening for melanoma: Measures and strategies that have consistently achieved early detection and cure
    • Shore, R. N., Shore, P., Monahan, N. M. & Sundeen, J. Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure. J. Drugs Dermatol. 10, 244-252 (2011).
    • (2011) J. Drugs Dermatol. , vol.10 , pp. 244-252
    • Shore, R.N.1    Shore, P.2    Monahan, N.M.3    Sundeen, J.4
  • 132
    • 35948956934 scopus 로고    scopus 로고
    • Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective
    • Woodward, E. R. et al. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG 114, 1500-1509 (2007).
    • (2007) BJOG , vol.114 , pp. 1500-1509
    • Woodward, E.R.1
  • 133
    • 41649107292 scopus 로고    scopus 로고
    • Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study
    • Kauff, N. D. et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J. Clin. Oncol. 26, 1331-1337 (2008).
    • (2008) J. Clin. Oncol. , vol.26 , pp. 1331-1337
    • Kauff, N.D.1
  • 134
    • 79952316878 scopus 로고    scopus 로고
    • Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-leiden mutation
    • Vasen, H. F. A. et al. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 140, 850-856 (2011).
    • (2011) Gastroenterology , vol.140 , pp. 850-856
    • Vasen, H.F.A.1
  • 135
    • 78649354230 scopus 로고    scopus 로고
    • Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer
    • Harinck, F. et al. Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer. Dig. Dis. 28, 670-678 (2010).
    • (2010) Dig. Dis. , vol.28 , pp. 670-678
    • Harinck, F.1
  • 136
    • 78650657873 scopus 로고    scopus 로고
    • Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: Preliminary analysis of the results of the IMPACT study
    • Mitra, A. V. et al. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int. 107, 28-39 (2011).
    • (2011) BJU Int. , vol.107 , pp. 28-39
    • Mitra, A.V.1
  • 137
    • 0028925807 scopus 로고
    • The impact of family history on early detection of prostate cancer
    • Narod, S. A. et al. The impact of family history on early detection of prostate cancer. Nat. Med. 1, 99-101 (1995).
    • (1995) Nat. Med. , vol.1 , pp. 99-101
    • Narod, S.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.